Plunkett Research Online: Regenerx Biopharmaceuticals Inc

REGENERX BIOPHARMACEUTICALS INC (RGRX:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

RegeneRx Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development of a novel therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair, and regeneration. It has formulated Thymosin beta 4 into three distinct product candidates in clinical development: RG.....



Regenerx Biopharmaceuticals Inc
Ticker: RGRX
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 301 208-9191
Fax: 301 280-1996
Address: 15245 Shady Grove Road
Suite 470
Rockville, MD 20850 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals
ContactsDescription
J. FinkelsteinCEO/President/Director
Allan GoldsteinChairman of the Board/Director/Founder/Other Executive Officer
See More
RegeneRx Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development of a novel therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair, and regeneration. It has formulated Thymosin beta 4 into three distinct product candidates in clinical development: RG.....See More See More

Auditor: CohnReznick LLP
Legal Advisor: Cooley LLP
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: